Currently holds a position at Elanco Animal Health Inc
Position | Company | Period |
---|---|---|
Independent Director | Elanco Animal Health Inc | Sept. 1, 2018 - |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2024-03-12 | 2024-03-08 |
Elanco Animal Health Inc
(ELAN)
|
B Purchase |
3,100
+4.2%
16.2950,494 USD |
3,100 +4.2% | 16.29 | 50,494 USD | |
2021-12-02 | 2021-11-30 |
Elanco Animal Health Inc
(ELAN)
|
B Purchase |
2,500
+9.7%
29.2573,123 USD |
2,500 +9.7% | 29.25 | 73,123 USD | |
2020-03-11 | 2020-03-09 |
Elanco Animal Health Inc
(ELAN)
|
B Purchase |
4,000
+31.3%
23.8495,360 USD |
4,000 +31.3% | 23.84 | 95,360 USD | |
2019-06-04 | 2019-06-03 |
Eli Lilly and Co
(LLY)
|
PS Planned sale |
16,000
-12.7%
116.721,867,520 USD |
16,000 -12.7% | 116.72 | 1,867,520 USD |